AME Ametek

FY2025 10-K
Filed: Feb 17, 2026
Health Care
Industrial Instruments For Measurement, Display, and ControlSEC EDGAR

Ametek (AME) filed its fiscal year 2025 10-K annual report with the SEC on Feb 17, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2025 10-K

Business Overview

  • Core business: global manufacturing of electronic instruments and electromechanical devices for industrial, aerospace, medical markets
  • New emphasis on AI tools in product development improving pace and quality of innovations in 2025
+3 more insights

Management Discussion & Analysis

  • Revenue $7,401.1M, up 6.6% YoY from $6,941.2M; EIG sales up 5.6%, EMG sales up 8.8%
  • Operating income $1,910.3M, up 7.3%; operating margin 25.8% vs 25.6% YoY
+3 more insights

Risk Factors

  • United States government tariffs on imports, potential adverse impact on costs and demand, situation evolving but no material 2025 effect reported
  • Exposure to global supply chain disruptions mitigated by geographic manufacturing footprint and strategic supply adjustments
+3 more insights

Financial Summary
XBRL

Revenue

$7.4B

Net Income

$1.5B

Operating Margin

25.8%

Net Margin

20.0%

ROE

13.9%

Total Assets

$16.1B

EPS (Diluted)

$6.40

Operating Cash Flow

$1.8B

Source: XBRL data from Ametek FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on Ametek

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available